184 related articles for article (PubMed ID: 28518415)
1. Systematic review of transarterial embolization for hepatocellular adenomas.
van Rosmalen BV; Coelen RJS; Bieze M; van Delden OM; Verheij J; Dejong CHC; van Gulik TM
Br J Surg; 2017 Jun; 104(7):823-835. PubMed ID: 28518415
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of transarterial embolization of hepatocellular adenomas.
van Rosmalen BV; Klompenhouwer AJ; de Graeff JJ; Haring MPD; de Meijer VE; Rifai L; Dokmak S; Rawashdeh A; Abu Hilal M; de Jong MC; Dejong CHC; Doukas M; de Man RA; IJzermans JNM; van Delden OM; Verheij J; van Gulik TM;
Br J Surg; 2019 Sep; 106(10):1362-1371. PubMed ID: 31313827
[TBL] [Abstract][Full Text] [Related]
3. Selective transcatheter arterial embolization for treatment of bleeding complications or reduction of tumor mass of hepatocellular adenomas.
Erdogan D; van Delden OM; Busch OR; Gouma DJ; van Gulik TM
Cardiovasc Intervent Radiol; 2007; 30(6):1252-8. PubMed ID: 17605070
[TBL] [Abstract][Full Text] [Related]
4. Systematic review of haemorrhage and rupture of hepatocellular adenomas.
van Aalten SM; de Man RA; IJzermans JN; Terkivatan T
Br J Surg; 2012 Jul; 99(7):911-6. PubMed ID: 22619025
[TBL] [Abstract][Full Text] [Related]
5. Management and outcome of hepatocellular adenoma with massive bleeding at presentation.
Klompenhouwer AJ; de Man RA; Thomeer MG; Ijzermans JN
World J Gastroenterol; 2017 Jul; 23(25):4579-4586. PubMed ID: 28740346
[TBL] [Abstract][Full Text] [Related]
6. Systematic review: benefits and harms of transarterial embolisation for treating hepatocellular adenoma.
Zhao C; Pei SL; Cucchetti A; Tong TJ; Ma YL; Zhong JH; Li LQ
Aliment Pharmacol Ther; 2017 Mar; ():. PubMed ID: 28318052
[TBL] [Abstract][Full Text] [Related]
7. Disappearance of Hepatocellular Adenoma in a Patient with Cornelia de Lange Syndrome after Treatment with Transcatheter Arterial Embolization.
Takata K; Kitaguchi T; Tokushige H; Nagata T; Miyayama T; Shibata K; Fukuda H; Yamauchi R; Fukunaga A; Tanaka T; Yokoyama K; Shakado S; Yoshimitsu K; Kusano H; Sakisaka S; Hirai F
Intern Med; 2024 Jun; 63(11):1569-1573. PubMed ID: 37866915
[TBL] [Abstract][Full Text] [Related]
8. Management of spontaneous haemorrhage and rupture of hepatocellular adenomas. A single centre experience.
Erdogan D; Busch OR; van Delden OM; Ten Kate FJ; Gouma DJ; van Gulik TM
Liver Int; 2006 May; 26(4):433-8. PubMed ID: 16629646
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for bleeding in hepatocellular adenoma.
Bieze M; Phoa SS; Verheij J; van Lienden KP; van Gulik TM
Br J Surg; 2014 Jun; 101(7):847-55. PubMed ID: 24760723
[TBL] [Abstract][Full Text] [Related]
10. Retrospective study on timing of resection of hepatocellular adenoma.
Klompenhouwer AJ; Bröker MEE; Thomeer MGJ; Gaspersz MP; de Man RA; IJzermans JNM
Br J Surg; 2017 Nov; 104(12):1695-1703. PubMed ID: 28857134
[TBL] [Abstract][Full Text] [Related]
11. Snapshot summary of diagnosis and management of hepatocellular adenoma subtypes.
Bioulac-Sage P; Sempoux C; Frulio N; Le Bail B; Blanc JF; Castain C; Laurent C; Trillaud H; Chiche L; Balabaud C
Clin Res Hepatol Gastroenterol; 2019 Feb; 43(1):12-19. PubMed ID: 30213653
[TBL] [Abstract][Full Text] [Related]
12. Hemorrhage of hepatocellular adenoma: a complication that can be treated by conservative management without surgery.
Dokmak S; Aussilhou B; Rasoaherinomenjanahary F; Ronot M; Dahdouh R; Ftériche FS; Cauchy F; Paradis V; Belghiti J; Soubrane O
HPB (Oxford); 2018 Dec; 20(12):1198-1205. PubMed ID: 31217088
[TBL] [Abstract][Full Text] [Related]
13. Transarterial (Chemo-)Embolization and Lipiodolization for Hepatic Haemangioma.
Furumaya A; van Rosmalen BV; Takkenberg RB; van Delden OM; Dejong CHC; Verheij J; van Gulik TM
Cardiovasc Intervent Radiol; 2019 Jun; 42(6):800-811. PubMed ID: 30783780
[TBL] [Abstract][Full Text] [Related]
14. Management of Hepatocellular Adenoma: Recent Advances.
Agrawal S; Agarwal S; Arnason T; Saini S; Belghiti J
Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1221-30. PubMed ID: 24909909
[TBL] [Abstract][Full Text] [Related]
15. Resection, transplantation and local regional therapies for liver adenomas.
Dokmak S; Cauchy F; Belghiti J
Expert Rev Gastroenterol Hepatol; 2014 Sep; 8(7):803-10. PubMed ID: 24957321
[TBL] [Abstract][Full Text] [Related]
16. Management of hepatocellular adenoma: comparison of resection, embolization and observation.
Karkar AM; Tang LH; Kashikar ND; Gonen M; Solomon SB; Dematteo RP; D' Angelica MI; Correa-Gallego C; Jarnagin WR; Fong Y; Getrajdman GI; Allen P; Kingham TP
HPB (Oxford); 2013 Mar; 15(3):235-43. PubMed ID: 23374365
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular Adenoma Risk Factors of Hemorrhage: Size Is Not the Only Concern!: Single-center Retrospective Experience of 261 Patients.
Julien C; Le-Bail B; Ouazzani Touhami K; Frulio N; Blanc JF; Adam JP; Laurent C; Balabaud C; Bioulac-Sage P; Chiche L
Ann Surg; 2021 Nov; 274(5):843-850. PubMed ID: 34334644
[TBL] [Abstract][Full Text] [Related]
18. Can a decision-making model be justified in the management of hepatocellular adenoma?
van Aalten SM; Witjes CD; de Man RA; Ijzermans JN; Terkivatan T
Liver Int; 2012 Jan; 32(1):28-37. PubMed ID: 22098685
[TBL] [Abstract][Full Text] [Related]
19. Bland embolization in the treatment of hepatic adenomas: preliminary experience.
Deodhar A; Brody LA; Covey AM; Brown KT; Getrajdman GI
J Vasc Interv Radiol; 2011 Jun; 22(6):795-9; quiz 800. PubMed ID: 21616432
[TBL] [Abstract][Full Text] [Related]
20. Management of ruptured hepatocellular adenoma.
Huurman VA; Schaapherder AF
Dig Surg; 2010; 27(1):56-60. PubMed ID: 20357452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
